You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-alcoholic Fatty Liver Disease

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Alcoholic Fatty Liver Disease Trial in Hong Kong (Ambulatory monitoring of liver fat, Standard of care)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Ambulatory monitoring of liver fat
  • Standard of care
  • Hong Kong, Select A State Or Province, China
    The University of Hong Kong
Mar 1, 2023

NAFLD, Non-alcoholic Fatty Liver Disease Trial in Sulaymaniyah (Beetroot juice, , Mediterranean diet alone (MeD))

Completed
  • NAFLD, Non-alcoholic Fatty Liver Disease
  • Beetroot juice
  • +3 more
  • Sulaymaniyah, Sulaimanyah, Iraq
    Hawal
Jun 8, 2023

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Al Ain, Abu Dhabi, United Arab Emirates
    Internal Medicine, College of Medicine and Health Sciences
Mar 1, 2023

Non-Alcoholic Fatty Liver Disease Trial (Calisthenics exercise)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Calisthenics exercise
  • (no location specified)
Sep 9, 2023

Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial in San Antonio (AZD7503 Intervention)

Active, not recruiting
  • Non-alcoholic Fatty Liver Disease
  • +5 more
  • AZD7503 Intervention
  • San Antonio, Texas
    Research Site
Jan 13, 2023

Non-Alcoholic Fatty Liver Disease Trial in Shanghai (2D ultrasound scan and MRI examination)

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • 2D ultrasound scan and MRI examination
  • Shanghai, China
    Xinhua Hospital affiliated to Shanghai Jiao Tong University Scho
Oct 18, 2023

Hepatic Disease Trial (Ketotifen, Vitamin E)

Not yet recruiting
  • Hepatic Disease
  • (no location specified)
Nov 13, 2022

Dynamic Post-Prandial Metabolism in Non-Alcoholic Fatty Liver

Completed
  • Liver Disease
  • Fatty Liver
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Non-Alcoholic Fatty Liver Disease Trial in Seoul (GODEX, Placebo)

    Enrolling by invitation
    • Non-Alcoholic Fatty Liver Disease
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Nov 30, 2023

    Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Obesity Trial in Boston (Endoscopic ultrasound shear wave

    Recruiting
    • Non-Alcoholic Fatty Liver Disease
    • +2 more
    • Endoscopic ultrasound shear wave elastography
    • Boston, Massachusetts
    • +1 more
    Feb 13, 2023

    Non-Alcoholic Fatty Liver Disease Trial in Tanta (Cholecalciferol, Placebo)

    Recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Tanta, Egypt
      Tanta Unuversity
    Oct 30, 2022

    Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation Trial in London (Faecal microbiota transplant)

    Recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Fecal Microbiota Transplantation
    • Faecal microbiota transplant
    • London, United Kingdom
      Division of Digestive Diseases/ Liver Unit, St Mary's Hospital C
    Aug 29, 2023

    NAFLD Cirrhosis Trial in New Delhi (Dapagliflozin, Standard of Care)

    Not yet recruiting
    • NAFLD Cirrhosis
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences
    May 5, 2023

    Dyslipidemias, Non-Alcoholic Fatty Liver Disease Trial in San Antonio (LY3885125, Placebo)

    Recruiting
    • Dyslipidemias
    • Non-Alcoholic Fatty Liver Disease
    • San Antonio, Texas
      Worldwide Clinical Trials, Early Phase Services LLC
    Aug 18, 2023

    Non-Alcoholic Fatty Liver Disease Trial in Toronto

    Recruiting
    • Non-Alcoholic Fatty Liver Disease
      • Toronto, Ontario, Canada
        Toronto General Hospital
      Nov 1, 2022

      Non-Alcoholic Fatty Liver Disease Trial in Helsinki (bariatric surgery)

      Enrolling by invitation
      • Non-Alcoholic Fatty Liver Disease
      • bariatric surgery
      • Helsinki, Finland
        Biomedicum 2U
      Sep 20, 2022

      Non-Alcoholic Fatty Liver Disease Trial in Athens (Early Time-Restricted Feeding Plus Hypocaloric Mediterranean Diet, Late

      Recruiting
      • Non-Alcoholic Fatty Liver Disease
      • Early Time-Restricted Feeding Plus Hypocaloric Mediterranean Diet
      • +2 more
      • Athens, Attica, Greece
      • +1 more
      May 10, 2023

      Non-Alcoholic Fatty Liver Disease, Time Restricted Feeding, Mobile Technology Trial in Seoul (Mobile application and wearable

      Recruiting
      • Non-Alcoholic Fatty Liver Disease
      • +2 more
      • Mobile application and wearable device
      • Time-restricted eating
      • Seoul, Korea, Republic of
        Hanyang University Seoul Hospital
      Feb 2, 2023

      Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma Trial in Roma (Handgrip strength test, total body

      Recruiting
      • Liver Cirrhosis
      • +2 more
      • Handgrip strength test
      • +2 more
      • Roma, RM, Italy
        CEMAD
      Oct 20, 2023

      Non-Alcoholic Fatty Liver Disease Trial in Rio de Janeiro

      Not yet recruiting
      • Non-Alcoholic Fatty Liver Disease
        • Rio de Janeiro, RJ, Brazil
          Federal University of Rio de Janeiro
        Jun 7, 2023

        Hepatic Inflammation, Fibrosis and Prognosis in CHB and NAFLD

        Recruiting
        • Chronic Hepatitis b
        • Non-alcoholic Fatty Liver Disease
          • Nanjing, China
            Nanjing Drum Tower Hospital
          Mar 2, 2023

          Non-Alcoholic Fatty Liver Disease Trial in Cairo (Cholecalciferol)

          Recruiting
          • Non-Alcoholic Fatty Liver Disease
          • Cairo, Egypt
            National hepatology and tropical medicine research institute
          Nov 3, 2022

          Simple Steatosis Non Fatty Liver Trial in Cairo (N acetyl cysteine with weight reduction)

          Recruiting
          • Simple Steatosis Non Fatty Liver
          • N acetyl cysteine with weight reduction
          • Cairo, Egypt
            NHTMRI
          Oct 18, 2022

          Non-Alcoholic Fatty Liver Disease Trial (MBS217, Placebo)

          Not yet recruiting
          • Non-Alcoholic Fatty Liver Disease
          • MBS217
          • Placebo
          • (no location specified)
          Jan 8, 2023

          Visceral Obesity, Non-Alcoholic Fatty Liver Disease Trial in Reus (Multi-ingredient of L-histidine, L-serine, L-carnosine and

          Not yet recruiting
          • Visceral Obesity
          • Non-Alcoholic Fatty Liver Disease
          • Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine
          • Placebo
          • Reus, Spain
            Eurecat
          Mar 28, 2023